Eosinophilic Esophagitis in Adults: A Concise Overview of an Evolving Disease

키워드

참고문헌 (77)

1. Liacouras CA, "Eosinophilic esophagitis : updated consensus recommendations for children and adults", J Allergy Clin Immunol, 128, pp.3~20 (2011)
2. Molina-Infante J, "Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults", Clin Gastroenterol Hepatol, 9, pp.110~117 (2011)
3. Weller PF, "The immunobiology of eosinophils", N Engl J Med, 324, pp.1110~1118 (1991)
4. Winter HS, "Intraepithelial eosinophils : a new diagnostic criterion for reflux esophagitis", Gastroenterology, 83, pp.818~823 (1982)
5. Landres RT, "Eosinophilic esophagitis in a patient with vigorous achalasia", Gastroenterology, 74, pp.1298~1301 (1978)
6. Picus D, "Eosinophilic esophagitis", AJR Am J Roentgenol, 136, pp.1001~1003 (1981)
7. Munch R, "Eosinophilic esophagitis, a rare manifestation of eosinophilic gastroenteritis", Schweiz Med Wochenschr, 112, pp.731~734 (1982)
8. Attwood SE, "Esophageal eosinophilia with dysphagia : a distinct clinicopathologic syndrome", Dig Dis Sci, 38, pp.109~116 (1993)
9. Hruz P, "Epidemiology of eosinophilic esophagitis", Dig Dis, 32, pp.40~47 (2014)
10. Giriens B, "Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013 : a population-based study", Allergy, 70, pp.1633~1639 (2015)
11. Prasad GA, "Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota", Clin Gastroenterol Hepatol, 7, pp.1055~1061 (2009)
12. Dellon ES, "Prevalence of eosinophilic esophagitis in the United States", Clin Gastroenterol Hepatol, 12, pp.589~596 (2014)
13. Noel RJ, "Eosinophilic esophagitis", N Engl J Med, 351, pp.940~941 (2004)
14. Fujiwara Y, "A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration", Intern Med, 51, pp.3235~3239 (2012)
15. Assiri AM, "Incidence and diagnostic features of eosinophilic esophagitis in a group of children with dysphagia and gastroesophageal reflux disease", Saudi Med J, 35, pp.292~297 (2014)
16. Blanchard C, "Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis", J Immunol, 184, pp.4033~4041 (2010)
17. Rothenberg ME, "Common variants at 5q22 associate with pediatric eosinophilic esophagitis", Nat Genet, 42, pp.289~291 (2010)
18. Amaral AF, "The locus C11orf30 increases susceptibility to poly-sensitization", Allergy, 70, pp.328~333 (2015)
19. Bonnelykke K, "Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization", Nat Genet, 45, pp.902~906 (2013)
20. Hsu CY, "Deimination of human filaggrin-2 promotes its proteolysis by calpain 1", J Biol Chem, 286, pp.23222~23233 (2011)
21. Raheem M, "The pathophysiology of eosinophilic esophagitis", Front Pediatr, 2, pp.41~ (2014)
22. Simon HU, "Immunopathogenesis of eosinophilic esophagitis", Dig Dis, 32, pp.11~14 (2014)
23. Straumann A, "Pediatric and adult eosinophilic esophagitis : similarities and differences", Allergy, 67, pp.477~490 (2012)
24. Gonsalves N, "Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors", Gastroenterology, 142, pp.1451~1459 (2012)
25. Lucendo AJ, "Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis : a prospective study on the food cause of the disease", J Allergy Clin Immunol, 131, pp.797~804 (2013)
26. Simon D, "Eosinophilic esophagitis and allergy", Dig Dis, 32, pp.30~33 (2014)
27. Tobey NA, "Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium", Am J Gastroenterol, 99, pp.13~22 (2004)
28. Croese J, "Clinical and endoscopic features of eosinophilic esophagitis in adults", Gastrointest Endosc, 58, pp.516~522 (2003)
29. Muller S, "Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis", Endoscopy, 39, pp.339~344 (2007)
30. Dellon ES, "Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease", Clin Gastroenterol Hepatol, 7, pp.1305~1313 (2009)
31. Spergel JM, "14 Years of eosinophilic esophagitis : clinical features and prognosis", J Pediatr Gastroenterol Nutr, 48, pp.30~36 (2009)
32. Lynch KL, "Gender is a determinative factor in the initial clinical presentation of eosinophilic esophagitis", Dis Esophagus, 29, pp.174~178 (2016)
33. Moawad FJ, "Correlation between eosinophilic oesophagitis and aeroallergens", Aliment Pharmacol Ther, 31, pp.509~515 (2010)
34. Spechler SJ, "Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis", Am J Gastroenterol, 102, pp.1301~1306 (2007)
35. Furuta GT, "Eosinophilic esophagitis in children and adults : a systematic review and consensus recommendations for diagnosis and treatment", Gastroenterology, 133, pp.1342~1363 (2007)
36. Ngo P, "Eosinophils in the esophagus : peptic or allergic eosinophilic esophagitis? : case series of three patients with esophageal eosinophilia", Am J Gastroenterol, 101, pp.1666~1670 (2006)
37. 이정호, "Clinical Analysis of Primary Eosinophilic Esophagitis", Journal of Neurogastroenterology and Motility (JNM), 19(2), pp.204~209 (2013), 대한소화기 기능성질환∙운동학회
38. Von Arnim U, "Eosinophilic esophagitis : update-pathogenesis, diagnosis and therapy", Z Gastroenterol, 52, pp.296~305 (2014)
39. Straumann A, "Eosinophilic esophagitis : red on microscopy, white on endoscopy", Digestion, 70, pp.109~116 (2004)
40. Peery AF, "Variable reliability of endoscopic findings with white-light and narrow-band imaging for patients with suspected eosinophilic esophagitis", Clin Gastroenterol Hepatol, 9, pp.475~480 (2011)
41. Kim HP, "The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis : a meta-analysis", Clin Gastroenterol Hepatol, 10, pp.988~996 (2012)
42. Lucendo AJ, "Guidelines on eosinophilic esophagitis : evidencebased statements and recommendations for diagnosis and management in children and adults", United European Gastroenterol J, 5, pp.335~358 (2017)
43. Peery AF, "Practice patterns for the evaluation and treatment of eosinophilic oesophagitis", Aliment Pharmacol Ther, 32, pp.1373~1382 (2010)
44. Sperry SL, "Toward uniformity in the diagnosis of eosinophilic esophagitis(EoE) : the effect of guidelines on variability of diagnostic criteria for EoE", Am J Gastroenterol, 106, pp.824~832 (2011)
45. Collins MH, "Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases", Gastroenterol Clin North Am, 43, pp.257~268 (2014)
46. Dellon ES, "ACG clinical guideline : evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis(EoE)", Am J Gastroenterol, 108, pp.679~692 (2013)
47. Konikoff MR, "Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis", Clin Gastroenterol Hepatol, 4, pp.1328~1336 (2006)
48. Straumann A, "Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis", Gastroenterology, 139, pp.1526~1537 (2010)
49. Filik L, "Montelukast and maintenance of steroid-induced remission in eosinophilic esophagitis", Dig Dis Sci, 57, pp.258~259 (2012)
50. Rodriguez-Sanchez J, "Effectiveness of serological markers of eosinophil activity in monitoring eosinophilic esophagitis", Rev Esp Enferm Dig, 105, pp.462~467 (2013)
51. Schlag C, "Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis", Aliment Pharmacol Ther, 42, pp.1122~1130 (2015)
52. Min SB, "Longitudinal evaluation of noninvasive biomarkers for eosinophilic esophagitis", J Clin Gastroenterol, 51, pp.127~135 (2017)
53. Rao GS, "Can eosinophil derived neurotoxin(EDN)act as a surrogate marker of disease activity in children with allergic eosinophilic esophagitis(AEE)?", Gastrointest Endosc, 59, pp.P103~ (2004)
54. Franciosi JP, "PedsQL eosinophilic esophagitis module : feasibility, reliability, and validity", J Pediatr Gastroenterol Nutr, 57, pp.57~66 (2013)
55. Mishra A, "Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia", Gastroenterology, 134, pp.204~214 (2008)
56. Aceves SS, "Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids", Allergy, 65, pp.109~116 (2010)
57. Carr S, "Eosinophilic esophagitis", Allergy Asthma Clin Immunol, 7(Suppl 1), pp.S8~ (2011)
58. Moawad FJ, "Randomized controlled trial comparing aerosolized swal-lowed fluticasone to esomeprazole for esophageal eosinophilia", Am J Gastroenterol, 108, pp.366~372 (2013)
59. Peterson KA, "Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis", Dig Dis Sci, 55, pp.1313~1319 (2010)
60. Dellon ES, "Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis", Gastroenterology, 143, pp.321~324 (2012)
61. Butz BK, "Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis", Gastroenterology, 147, pp.324~333 (2014)
62. Miehlke S, "A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis", Gut, 65, pp.390~399 (2016)
63. Tan ND, "Steroids therapy for eosinophilic esophagitis : systematic review and meta-analysis", J Dig Dis, 16, pp.431~442 (2015)
64. Remedios M, "Eosinophilic esophagitis in adults : clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate", Gastrointest Endosc, 63, pp.3~12 (2006)
65. Netzer P, "Corticosteroid-dependent eosinophilic oesophagitis : azathioprine and 6-mercaptopurine can induce and maintain longterm remission", Eur J Gastroenterol Hepatol, 19, pp.865~869 (2007)
66. Liacouras CA, "Eosinophilic esophagitis : a 10-year experience in 381children", Clin Gastroenterol Hepatol, 3, pp.1198~1206 (2005)
67. Attwood SE, "Eosinophilic oesophagitis : a novel treatment using Montelukast", Gut, 52, pp.181~185 (2003)
68. Straumann A, "Anti-interleukin-5 antibody treatment(mepolizumab)in active eosinophilic oesophagitis : a randomised, placebo-controlled, doubleblind trial", Gut, 59, pp.21~30 (2010)
69. Spergel JM, "Reslizumab in children and adolescents with eosinophilic esophagitis : results of a double-blind, randomized, placebocontrolled trial", J Allergy Clin Immunol, 129, pp.456~463 (2012)
70. Rothenberg ME, "Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis", J Allergy Clin Immunol, 135, pp.500~507 (2015)
71. Kelly KJ, "Eosinophilic esophagitis attributed to gastroesophageal reflux : improvement with an amino acid-based formula", Gastroenterology, 109, pp.1503~1512 (1995)
72. Kagalwalla AF, "Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis", Clin Gastroenterol Hepatol, 4, pp.1097~1102 (2006)
73. Molina-Infante J, "Four-food group elimination diet for adult eosinophilic esophagitis : a prospective multicenter study", J Allergy Clin Immunol, 134, pp.1093~1099 (2014)
74. Wolf WA, "Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis", Clin Gastroenterol Hepatol, 12, pp.1272~1279 (2014)
75. Schoepfer AM, "Esophageal dilation in eosinophilic esophagitis : effectiveness, safety, and impact on the underlying inflammation", Am J Gastroenterol, 105, pp.1062~1070 (2010)
76. Bohm ME, "Review article : oesophageal dilation in adults with eosinophilic oesophagitis", Aliment Pharmacol Ther, 33, pp.748~757 (2011)
77. Jacobs JW Jr, "A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis", Dig Dis Sci, 55, pp.1512~1515 (2010)

관련 논문AI추천